Estrella Immunopharma, Inc.
ESLA
$0.963
-$0.0065-0.67%
NASDAQ
| 06/30/2025 | 03/31/2025 | 09/30/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -- | -- | -91.88% | -91.88% | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | 215.27% | 215.27% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -66.76% | -89.06% | -91.83% | -91.83% | 61.84% |
|
|
|||||
| Total Current Assets | -66.76% | -89.06% | -91.83% | -91.83% | 61.84% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -33.09% | -71.69% | -86.34% | -86.34% | 47.08% |
|
|
|||||
| Total Accounts Payable | -- | -- | -99.95% | -99.95% | -- |
| Total Accrued Expenses | -- | -- | 17.21% | 17.21% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -83.33% | -83.33% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -99.15% | -99.15% | -- |
| Total Other Current Liabilities | -- | -- | -99.15% | -99.15% | -- |
| Total Current Liabilities | 4,922.25% | 2,986.79% | -82.70% | -82.70% | -98.15% |
|
|
|||||
| Total Current Liabilities | 4,922.25% | 2,986.79% | -82.70% | -82.70% | -98.15% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 4,922.25% | 2,986.79% | -82.70% | -82.70% | -98.15% |
|
|
|||||
| Common Stock & APIC | -- | -- | 0.00% | 0.00% | -- |
| Retained Earnings | -61.93% | -67.41% | -62.72% | -62.72% | -59.99% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -242.62% | -121.55% | -92.59% | -92.59% | 136.39% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -242.62% | -121.55% | -92.59% | -92.59% | 136.39% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -- | -- | -92.59% | -92.59% | -- |
|
|
|||||